Found 7 matching trials
Reduced PCV Dosing Schedules in South African Infants PHASE3 This study will evaluate the immunogenicity of a reduced dosing schedule of...
Show More Location
Chris Hani Baragwanath Academic Hospital
Learn More & Join Trial
Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy PHASE2 The study hypothesis is that a "reinforced" pneumococcal combined vaccine s...
Show More Location
Pôle de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques " Hôpital Cochin, Assistance Publique-Hôpitaux de Paris
Learn More & Join Trial
Impact of Vaccines on Antimicrobial Microbial Resistance N/A Vaccination is a potentially critical component of efforts to arrest develo...
Show More Location
Malawi Liverpool Wellcome Programme
Learn More & Join Trial
Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) PHASE3 The purpose of this study is 1) to evaluate the safety and tolerability of ...
Show More Location
Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
Learn More & Join Trial
A Phase 3 Study to Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13 PHASE3 The goal of this clinical trial is to evaluate the immunogenicity and safet...
Show More Location
RSUP Prof. Dr. I.G.N.G Ngoerah
Learn More & Join Trial
Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso PHASE4 This study aims to evaluate the immunogenicity and reactogenicity of 13-val...
Show More Location
CSPS Accart-Ville
Learn More & Join Trial
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children N/A This study will evaluate the persistence of immunogenicity following a redu...
Show More Location
Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU
Learn More & Join Trial